These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32182690)

  • 1. Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics.
    Moisi MI; Rus M; Bungau S; Zaha DC; Uivarosan D; Fratila O; Tit DM; Endres L; Nistor-Cseppento DC; Popescu MI
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32182690
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
    Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
    Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
    Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
    Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
    Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
    Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
    Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
    Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renal function on patients with acute coronary syndromes: 15,593 patient-years study.
    Kuźma Ł; Małyszko J; Kurasz A; Niwińska MM; Zalewska-Adamiec M; Bachórzewska-Gajewska H; Dobrzycki S
    Ren Fail; 2020 Nov; 42(1):881-889. PubMed ID: 32862755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of In-hospital Mortality in Patients Presenting with Acute Coronary Syndromes in a Tertiary Cardiac Center in Dhaka, Bangladesh.
    Cader FA; Kabir CS; Nasrin S; Amin MN; Haq MM
    Mymensingh Med J; 2022 Oct; 31(4):1057-1067. PubMed ID: 36189552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide and pulmonary echography are predictors of acute heart failure needing early mechanical ventilation in acute coronary syndrome.
    Cristo-Ropero MJ; Garcia-Rubira JC; Rivera-Rabanal FJ; Seoane-García T; Madrona-Jiménez L; Izquierdo-Bajo Á; Hernández-Meneses B; Vilches-Arenas A; Hidalgo-Urbano R
    Coron Artery Dis; 2024 Nov; 35(7):556-563. PubMed ID: 38828510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction.
    Celebi S; Celebi OO; Cetin S; Cetin HO; Tek M; Gokaslan S; Amasyali B; Berkalp B; Diker E; Aydogdu S
    Arq Bras Cardiol; 2019 Dec; 113(6):1129-1137. PubMed ID: 31664316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.
    Farhan S; Clare RM; Jarai R; Giugliano RP; Lokhnygina Y; Harrington RA; Kristin Newby L; Huber K
    Int J Cardiol; 2017 Apr; 232():264-270. PubMed ID: 28089149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.